Gene therapy for Brugada syndrome
- PMID: 35764821
- DOI: 10.1038/s41569-022-00744-3
Gene therapy for Brugada syndrome
Comment on
-
Gene therapy targeting protein trafficking regulator MOG1 in mouse models of Brugada syndrome, arrhythmias, and mild cardiomyopathy.Sci Transl Med. 2022 Jun 8;14(648):eabf3136. doi: 10.1126/scitranslmed.abf3136. Epub 2022 Jun 8. Sci Transl Med. 2022. PMID: 35675436
References
Original article
-
- Yu, G. et al. Gene therapy targeting protein trafficking regulator MOG1 in mouse models of Brugada syndrome, arrhythmias, and mild cardiomyopathy. Sci. Transl. Med. 14, eabf3136 (2022) - DOI
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources